ArticleCell death & disease2026

Correction: Targeting 3-phosphoinositide-dependent protein kinase 1 associated with drug-resistant renal cell carcinoma using new oridonin analogs.

Jiancheng Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.